Sponsor Check › Person
Related person on Form D filings · address states as listed: PA, NJ, CA, MD, GA, WA · listed Jul 22, 2009 → Jun 30, 2026
Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: not yet · SEC enforcement last checked: not yet
Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
Not yet searched.
Sources to be searched: CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
Search queued. Results are added automatically; check back later or follow this page to be notified.
Not yet searched.
Sources to be searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons are made for sponsors and sponsor groups, not individual people.
1 of 37 offerings reports sales commissions totalling $2,250,000; 0 report finder's fees; 2 report proceeds to related persons totalling $2,532,000. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Jun 30, 2026 D File 021-589036 | $0 (est.) | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 8, 2025 D File 021-560187 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 29, 2022 D File 021-469166 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 27, 2021 D File 021-397372 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 15, 2018 D File 021-314736 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 7, 2016 D/A File 021-230865 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 7, 2016 D File 021-260852 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 2, 2015 D File 021-246857 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 27, 2015 D File 021-232909 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 27, 2014 D File 021-219978 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 13, 2014 D File 021-217228 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 18, 2014 D File 021-212053 | $2,250,000 | $0 | $0 | Cowen and Company, LLC BrokerCheck CRD 7616 ↗ via Cowen and Company, LLC (CRD 7616 ↗) |
| EDGAR ↗ | Jan 8, 2014 D File 021-209492 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 2, 2013 D File 021-203852 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 24, 2013 D File 021-200199 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 31, 2013 D File 021-191139 | $0 | $0 | $532,000 (est.) | None no CRD number reported |
| EDGAR ↗ | Oct 5, 2012 D File 021-185102 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 5, 2012 D File 021-180714 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 7, 2012 D File 021-179387 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 6, 2011 D/A File 021-154341 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 25, 2011 D File 021-160301 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 5, 2011 D/A File 021-152645 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 24, 2011 D File 021-157286 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 3, 2010 D File 021-149925 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 30, 2010 D File 021-147084 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 14, 2010 D File 021-144909 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 1, 2010 D File 021-144359 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 24, 2010 D File 021-143991 | $0 | $0 | $2,000,000 (est.) | None listed on this filing |
| EDGAR ↗ | Mar 12, 2010 D File 021-82434 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 11, 2010 D File 021-107416 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 7, 2010 D File 021-56377 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Sep 16, 2009 D File 021-102365 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 4, 2009 D File 021-59576 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 22, 2009 D File 021-101715 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 18, 2009 D File 021-132078 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 10, 2009 D File 021-131856 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 27, 2009 D/A File 021-118709 | $0 | $0 | $0 | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
| Source | Issuer | Role | Filed | Form | Offering | Sold | Investors | Min. investment |
|---|---|---|---|---|---|---|---|---|
| EDGAR ↗ | SonoThera, Inc. | Director | Jun 30, 2026 | D | $125,450,218 similar: $2,000,000–$14,000,000 | $125,450,218 | 22 similar: 1–19 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | ThirdLaw Molecular, Inc. | Director | Oct 8, 2025 | D | $5,500,000 similar: $2,000,000–$19,999,994 | $5,500,000 | 4 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | SonoThera, Inc. | Director | Dec 29, 2022 | D | $60,750,000 similar: $2,000,000–$19,999,994 | $30,375,000 | 12 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | ALIMERA SCIENCES INC | Director | Apr 27, 2021 | D | $10,000,000 similar: $1,694,259–$16,000,000 | $10,000,000 | 1 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | WindMIL Therapeutics, Inc. | Executive Officer, Director | Jun 15, 2018 | D | $32,525,358 similar: $2,000,000–$19,999,994 | $32,525,358 | 11 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Domain Partners IX, L.P. group: Domain | Executive Officer | Dec 7, 2016 | D/A | Indefinite similar: $155,000–$5,250,000 | $163,636,363 | 6 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | WindMIL Therapeutics, Inc. | Executive Officer, Director | Apr 7, 2016 | D | $10,000,000 similar: $2,000,000–$19,999,994 | $10,000,000 | 4 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Domain Partners IX, L.P. group: Domain | Executive Officer | Dec 3, 2015 | D/A | Indefinite similar: $155,000–$5,250,000 | $163,636,363 | 6 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | Kona Medical, Inc. | Director | Sep 2, 2015 | D | $22,376,012 similar: $2,000,000–$19,999,994 | $10,000,300 | 17 similar: 2–16 | $1 similar: $10,000–$50,000 |
| EDGAR ↗ | Bionano Genomics, Inc. | Director | Jan 27, 2015 | D | $68,443,451 similar: $1,694,259–$16,000,000 | $68,443,451 | 17 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Domain Partners IX, L.P. group: Domain | Executive Officer | Dec 24, 2014 | D | Indefinite similar: $155,000–$5,250,000 | $163,636,363 | 6 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | Bionano Genomics, Inc. | Director | Jun 27, 2014 | D | $6,139,997 similar: $1,694,259–$16,000,000 | $5,000,500 | 5 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | ORAYA THERAPEUTICS INC | Director | May 13, 2014 | D | $38,232,006 similar: $1,100,015–$10,001,163 | $25,132,051 | 5 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | ALIMERA SCIENCES INC | Director | Feb 18, 2014 | D | $37,500,000 similar: $1,694,259–$16,000,000 | $37,500,000 | 21 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Bionano Genomics, Inc. | Director | Jan 8, 2014 | D | $15,000 similar: $1,694,259–$16,000,000 | $15,000 | 1 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Bionano Genomics, Inc. | Director | Oct 2, 2013 | D | $13,663,054 similar: $1,694,259–$16,000,000 | $10,001,000 | 5 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Cartiva, Inc. group: Carticept | Director | Jul 24, 2013 | D | $4,482,240 similar: $829,831–$9,999,998 | $4,312,712 | 9 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Corridor Pharmaceuticals, Inc. group: Levitt Grossman | Director | Jan 31, 2013 | D | $1,800,000 similar: $2,000,000–$19,999,994 | $1,558,429 | 9 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | ALIMERA SCIENCES INC | Director | Oct 5, 2012 | D | $40,000,000 similar: $1,694,259–$16,000,000 | $40,000,000 | 0 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Bionano Genomics, Inc. | Director | Jul 5, 2012 | D | $13,939,494 similar: $1,694,259–$16,000,000 | $11,573,201 | 6 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Kona Medical, Inc. | Director | Jun 7, 2012 | D | $45,000,005 similar: $2,000,000–$19,999,994 | $30,000,002 | 10 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Kona Medical, Inc. | Director | Jun 6, 2011 | D/A | $10,857,236 similar: $2,000,000–$19,999,994 | $10,857,236 | 13 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | ALIMERA SCIENCES INC | Director | May 25, 2011 | D | $332,486 similar: $1,694,259–$16,000,000 | $332,486 | 0 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | ORAYA THERAPEUTICS INC | Director | Apr 5, 2011 | D/A | $20,875,000 similar: $1,100,015–$10,001,163 | $20,875,000 | 7 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Bionano Genomics, Inc. | Director | Mar 24, 2011 | D | $23,265,909 similar: $2,000,000–$19,999,994 | $23,265,909 | 9 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Kona Medical, Inc. | Director | Jan 25, 2011 | D | $7,954,477 similar: $2,000,000–$19,999,994 | $7,954,477 | 11 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | ORAYA THERAPEUTICS INC | Director | Dec 29, 2010 | D | $5,000,000 similar: $1,100,015–$10,001,163 | $5,000,000 | 7 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Nanothera Corp | Director | Nov 3, 2010 | D | $14,000,062 similar: $829,831–$9,999,998 | $1,300,062 | 2 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Tobira Therapeutics, Inc. | Director | Aug 30, 2010 | D | $31,199,776 similar: $2,000,000–$19,999,994 | $14,199,776 | 6 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Tobira Therapeutics, Inc. | Executive Officer, Director | Jul 14, 2010 | D | $10,999,999 similar: $2,000,000–$19,999,994 | $4,999,999 | 5 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Kona Medical, Inc. | Director | Jul 1, 2010 | D | $2,600,441 similar: $1,100,015–$10,001,163 | $2,600,441 | 12 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Corridor Pharmaceuticals, Inc. group: Levitt Grossman | Director | Jun 24, 2010 | D | $14,475,000 similar: $2,000,000–$19,999,994 | $13,012,475 | 8 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Carticept Medical Inc group: Carticept | Director | Mar 12, 2010 | D | $20,000,002 similar: $829,831–$9,999,998 | $10,000,001 | 0 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Tobira Therapeutics, Inc. | Executive Officer, Director | Mar 11, 2010 | D | $4,000,000 similar: $2,000,000–$19,999,994 | $4,000,000 | 5 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | GI DYNAMICS, INC. group: Gi Dynamics | Director | Jan 7, 2010 | D | $15,000,000 similar: $2,000,000–$19,999,994 | $15,000,000 | 1 similar: 2–16 | $15,000,000 similar: $10,000–$50,000 |
| EDGAR ↗ | Optherion Inc | Director | Sep 16, 2009 | D | $9,454,166 similar: $2,000,000–$19,999,994 | $5,000,000 | 10 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | ALIMERA SCIENCES INC | Director | Sep 4, 2009 | D | $5,000,000 similar: $1,694,259–$16,000,000 | $5,000,000 | 25 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | ORAYA THERAPEUTICS INC | Director | Jul 22, 2009 | D | $20,875,000 similar: $1,100,015–$10,001,163 | $20,875,000 | 7 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Domain Partners VIII, L.P. group: Domain | Executive Officer | Jun 18, 2009 | D | Indefinite similar: $155,000–$5,250,000 | $371,070,000 | 32 similar: 4–27 | $5,000,000 similar: $1,000–$100,000 |
| EDGAR ↗ | DP VIII Associates, L.P. group: Domain | Executive Officer | Jun 10, 2009 | D | Indefinite similar: $155,000–$5,250,000 | $3,673,000 | 35 similar: 4–27 | $50,000 similar: $1,000–$100,000 |
| EDGAR ↗ | OCEANA THERAPEUTICS, INC. | Director | May 27, 2009 | D/A | $50,000,001 similar: $1,694,259–$16,000,000 | $3,000,000 | 4 similar: 1–13 | $16,770 similar: $10,000–$55,000 |
Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.
"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years (6 industry/exemption sets on this page); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Not linked to this profile — a second identifier (same issuer, same sponsor group) was not found. Could be the same person or a different one.
People and management entities the issuers listed as related persons on the same Form D filings as Brian Halak. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Export this report as PDF (members · included free during the launch period)
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Brian Halak appears on a new Form D, or when a court case or SEC action is matched to them. See plans →